Parmer Cardiff Waterside has embarked on a five-year investment programme to soften the streetscape, modernise entrances, develop the amenity offering and re-orientate the properties to create a sense of place, encourage ideas, productivity and wellness.
Edward Lockyer, Head of European Office and Industrial Management at Parmer said, “We are looking forward to working with the team at Cooke & Arkwright on the Parmer Cardiff office campus in the Bay.
“Parmer Cardiff can accommodate office requirements from 500 square feet to new build corporate head quarter buildings up to 360,000 sq.ft. Parmer Cardiff Waterside is a unique urban business campus set in outstanding waterfront surroundings and provides all the services and amenities demanded by the modern occupier.”
Ben Bolton, Director of Business Space at Cooke & Arkwright added, “We are very pleased to take on this instruction for Parmer Cardiff Waterside. Our appointment continues the firm's long-standing involvement with Cardiff Bay, from its inception with the Cardiff Bay Development Company, to latter phases working with ABP and Aviva along the way.
“Our instruction is also timely as Cardiff Council is committed to move ahead with the new 15,000-seater Cardiff Arena at the Red Dragon Centre, along with improved transport links to the city centre. We anticipate that this will turbo-charge the area once again and we look forward to working with Parmer Cardiff to help deliver the further development and evolution of Cardiff Waterside and the Cardiff Bay area.”
Parmer Cardiff Waterside is home to a range of local and national businesses from across the financial and professional services, life sciences and creative business sectors including Atradius, Lloyds Bank, ITV, Arup, Regus, the CBI, Sapiens, Credit Safe, KPMG and the Welsh Government Life Science Hub.
The global Parmer Innovations portfolio comprises more than 3m sq. ft. of office space and 1,000 developable hectares in the US and the UK, and is home to several leading international businesses including Apple, GlaxoSmithKline and Virgin Media.